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Abstract
Background Carcinoma ex pleomorphic adenoma is
exceedingly rare in minor salivary glands of the oral
cavity. We present a case of carcinoma ex pleomorphic
adenoma (CEPA) of the buccal mucosa in a 47-year-old
Turkish patient. The buccal mass was of a size of 1.5 cm
located in the left cheek. Pleomorphic adenoma was the
tentative diagnosis.
Methods The tumor was removed under local anesthesia.
Histopathologic evaluation revealed a preexisting pleomor-
phic adenoma associated with adenoid tumor component
with tubulo-cystic and papillary or pseudopapillary
structures; CEPA was diagnosed. Capsular integrity was
incomplete with infiltration by islands of metaplastic/
dysplastic epithelium.
Results Secondary surgery of the site was performed. No
tumor tissue could be detected in the resection specimen.
The patient is free of recurrence since 9 months.
Keywords Minor salivary gland tumor .
Pleomorphic adenoma . Carcinoma ex pleomorphic adenoma
Introduction
Carcinoma ex pleomorphic adenoma (CEPA) is defined as a
pleomorphic adenoma from which an epithelial malignancy
is derived [1]. CEPAs comprise about 3.6% of all salivary
tumors and 12% of all salivary malignancies. Most CEPAs
arise in the parotid gland. The proportion of benign versus
malignant components can be variable.
CEPAs are subclassified into non-invasive, minimally
invasive (about 1.5 mm penetration of the malignant
component into extra capsular tissue), and invasive (more
than 1.5 mm penetration into extra capsular tissue) [1].
Recommended therapy is wide local excision, however,
improved prognosis for minimally invasive tumors has
been confirmed [2].
We present a case of CEPAwith minimal invasion of the
capsule in a buccal minor salivary gland of a 47-year-old
male patient.
Case presentation
A 47-year-old Turkish male patient was referred by his
medical practitioner for diagnosis and treatment of "a lump
in the left cheek". The patient was a non-smoker. General
health status was unremarkable. The patient had realized
that there was a mass in his left cheek, but could not state
for how long it had been present. Because his wife urged
him to seek medical advice, he went to see his general
medical practitioner.
Extraoral inspection did not reveal any pathology of the
left cheek. Palpation of submandibular and cervical
lymphnodes was negative. Clinically, the buccal oral
mucosa of the left side was of normal color and texture.
There were no signs of inflammation. The salivary papilla
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of the parotid gland was of normal size. The left parotid
gland produced saliva of normal quality and quantity.
Palpation of the left cheek revealed a swelling located in the
area corresponding to the first mandibular premolar and to
the first molar. The mass was of a size of about 1.5 cm, and
of an oval to round shape. It was firm, painless, and not
fixed to the underlying soft tissues of the cheek.
After local anesthesia a horizontal incision of 2 cm
allowed for exposure of the tumor mass. The lesion was
encapsulated, and could easily be removed in toto by blunt
preparation. The wound was closed using non-resorbable
sutures. Wound healing was uneventful. The surgical
specimen was of a size of 1.8×1.3 cm (Fig. 1). Macro-
scopically, the tumor appeared to be encapsulated. When
cut open (Fig. 2), a solid tumor mass of a yellowish-pinkish
color was obvious. The specimen was immersed in
formalin (4%), and sent to the pathology laboratory with
the tentative diagnosis of pleomorphic adenoma.
Histopathologically, a salivary gland tumor was diagnosed
with residual normal salivary mucous gland tissue adjacent to
the tumor (Fig. 3). The tumor was composed of pre-existing
areas of pleomorphic adenoma characterized by a typical
tubular-glandular component in a myxoid stroma (Fig. 4). A
transitional zone showed myoepithelial and epithelial cells,
and in close association adenoid tumor tissue with tubulo-
cystic and papillary or pseudopapillary structures (Fig. 5).
Cellular details revealed moderate nuclear pleomorphism, loss
of chromatin, prominent nucleoli, and moderate mitotic
activity. Capsular integrity was incomplete, and infiltration
by islands of metaplastic epithelial cells of the capsule was
observed (Figs. 6 and 7). Lymphangio-invasion could not
clearly be demonstrated. With the presence of atypia and
infiltration of the capsule, the diagnosis of carcinoma ex
pleomorphic adenoma, minimal invasive variant, was made.
With this rare and unexpected histopathological diagnosis,
the therapeutic regimen had to be reconsidered. The patient
was referred to a maxillo-facial surgery unit for a more
radical resection at the site of the former tumor. Three weeks
after initial removal of the tumor, the second resection was
performed in general anesthesia at the site of the primary
tumor. Neck dissection was not performed. The specimen,
which was submitted for histopathological diagnosis was of
a size of 14×8×8 mm. The excised specimen, proofed to be
free of tumor cells, and exhibited connective scar tissue in
skeletal muscle tissue. Multinucleated giant cells, an inflam-
matory infiltration and sero-mucous salivary gland tissue,
were also observed.
Nine months postoperatively, the patient is considered
free of disease and is scheduled for follow-up controls
every 3 months.
Fig. 1 Surgical specimen of the buccal tumor. Macroscopically, the
capsule of the specimen seems to be intact
Fig. 2 When cut open, the specimen shows the presence of a solid
tumor. A capsule seems to be present
Fig. 3 Adjacent to neoplastic tissue (*) sero-mucous salivary gland tissue
(arrow) is seen (hematoxylin-eosin stain, original magnification ×25)
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Discussion
Few series of intraoral minor salivary gland tumors have
been published. One of the first extensive case series has
been published by Chaudhry and coworkers [3]. This study
included 94 own cases and 1,320 cases reported in the
literature (1927-1960) with a total of 1,414 cases. From
the 733 cases of pleomorphic adenoma, 38 occurred in the
cheek compared to 476 cases of the palate indicating that
pleomorphic adenomas of the cheek are quite rare. When
considering malignant tumors alone (n=520), 26 cases of
"malignant pleomorphic adenomas" (as this was the
terminology in the 1960s) were registered (12 males, eight
females, six non-specified/n.s.; age range 20–92 yrs,
average age 48 yrs). Five cases of these were located in
the cheek (13 palate, one lower lip, five jaws, and two n.s.).
Out of the 94 cases from the authors own files, three cases
of "malignant pleomorphic adenoma" of the palate were
recorded and none were reported for the cheeks.
In 2005, Yih et al. reviewed 213 cases of minor salivary
glands tumors of which 94 were malignant (44%) [4]. Two
cases of carcinoma ex pleomorphic adenoma were recorded
(0.9%). One case occurred in the buccal mucosa (male,
37 yrs); the other was located in the retromolar area (male,
75 yrs).
In a clinico-pathological study from Brazil, 546 cases of
intraoral minor salivary gland tumors were reported [5]. Of
these, only two cases of CEPA (0.4%) were recorded. One
case was located at the buccal mucosa; the other case was
located at the alveolar ridge.
Fig. 7 Infiltration of capsular structures by an island of epithelial
tumor cells (*; hematoxylin-eosin stain, original magnification ×100)
Fig. 6 Microphoto showing incompleteness of capsular integrity with
infiltration of epithelial tumor islands (*; hematoxylin-eosin stain,
original magnification ×50)
Fig. 5 Transitional area showing myoepithelial and epithelial cells in
close association with adenoid tumor tissue revealing tubulo-cystic
(black *), papillary (white *), and pseudopapillary (arrow) structures
(hematoxylin-eosin stain, original magnification ×50)
Fig. 4 Microphoto showing parts of the pre-existing pleomorphic
adenoma characterized by a tubulo-glandular (arrow) component in a
myxoid stroma (*) (hematoxylin-eosin stain, original magnification ×50)
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In another study of tumors of minor salivary glands [n=75,
46 cases of malignant tumors (61.3%)] from Libya, two cases
of CEPA were diagnosed [6]. Generally, there is agreement
that the incidence of malignant tumors in minor salivary
glands is high, ranging between 38.0% and 82% [10].
Recently, a large study from China has been published
comprising 3,461 cases of salivary gland tumors which
have been collected over a 50-year period [7]. One
thousand three hundred ninety-two malignant tumors have
been recorded of which 145 were classified as CEPAs: 81
were located in the parotid glands, 54 in the palate, four in
the submandibular gland, and six in the floor of the mouth.
No case of CEPA affecting the cheek was registered. From
these data, it may be concluded that pleomorphic adenomas
of minor salivary glands of the cheek are quite uncommon,
and that CEPA in this anatomic region appears to be an
extremely rare entity.
Reviews on CEPA are rare and usually focus on major
salivary glands [8, 9]. A direct comparison of CEPAs of
major and minor salivary glands may be misleading.
However, some understanding of this tumor entity might
be derived from such reviews. In a clinico-pathologic
review of 73 cases of CEPA in major salivary glands [9],
66 patients had primary and seven had recurrent tumors (47
males, 26 females; mean age 61 yrs). Metastasis occurred in
56% regionally and distantly in 44% of the cases. At
3 years, overall survival was 39%, and at 5 years 30%. The
most frequent clinical complaint was a mass, present in 61
of 66 primary tumor patients (92%). These data show that
CEPA of the major salivary glands has to be considered an
aggressive entity with high tendency for recurrence and
fatal outcome. Generally, this statement may also be true
for cases of CEPA of the buccal mucosa and other minor
salivary glands.
Factors such as size of the neoplasia, persistence, and
location of the tumor are of importance for the prognosis. In
addition, the histopathologic sub-classification and grading
of the tumor are also of prognostic relevance. Carcinomas
ex pleomorphic adenomas are sub-classified into non-
invasive, minimally invasive, and invasive. The first two
groups have an excellent prognosis, while the latter has a
more guarded prognosis [1].
In the present case, histopathological evaluation revealed
definite but minimal invasion of the capsule with an
invasive component of the malignant part of the tumor. In
addition, the capsule was incomplete, particularly in the
area of infiltration. As was expected, the surgical specimen
after secondary surgery was free of malignant tumor tissue.
Due to the histological findings in the primary tumor and
the resection specimen of secondary surgery, this case was
classified as minimal invasive and, therefore, the prognosis
was expected to be good to very good. Postoperative
controls, however, over a prolonged period of time, are
mandatory.
This case shows that unexpected malignancy may occur in
what primarily is considered to be a frank benign tumor of
salivary gland tissue, and that only careful histopathological
evaluation can help in the detection of such extremely rare
salivary gland tumors including carcinoma ex pleomorphic
adenoma. A recently published case report also raised the
problem of a misleading histological diagnosis of a polymor-
phous low-grade adenocarcinoma in situ ex pleomorphic
adenoma in a palatal minor salivary gland [10].
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